Source: Healio News
Allogeneic hematopoietic cell transplantation showed potential in patients with high-risk multiple myeloma, according to findings presented at the ASCO Annual Meeting.
Allogeneic hematopoietic cell transplantation has always been “a very difficult topic” in multiple myeloma, but the approach may be “more feasible” for younger patients with very aggressive disease in certain situations, Cristina Gasparetto, MD, director of the multiple myeloma program at Duke University, told Healio in a video interview.
“We were pleasantly surprised by the favorable outcome in this